| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cda4fa78b29508d0f009dacc02eaa8eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23G3-364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23G4-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
| filingDate |
2011-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_488f753abb257c50412430bbc013e8a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab3902f88cfe79b5eb7761398c38102a |
| publicationDate |
2013-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2013133288-A |
| titleOfInvention |
Coaggregation inhibitor of oral bacteria |
| abstract |
[PROBLEMS] To prevent the growth of F. nucleatum and P. intermedia has great significance in preventing periodontal disease and preventing and reducing halitosis. In addition, since these bacterial species are known to coaggregate, inhibition of this coaggregation is expected to effectively prevent and reduce periodontal disease and bad breath originating from these bacterial species. it can. However, since these bacterial species are present in the oral cavity, suppression of coaggregation by a method that is not harmful to the human body is required. According to the coaggregation inhibitor of F. nucleatum and P. intermedia characterized by containing lactoferrin, coaggregation of these bacterial species can be inhibited without harm to the human body. [Selection] Figure 1 |
| priorityDate |
2011-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |